These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term safety of cyclosporine in renal transplant recipients: worldwide experience. Bernabeu M; Krupp P; Wiskott E Transplant Proc; 1993 Aug; 25(4 Suppl 3):17-9. PubMed ID: 8351707 [No Abstract] [Full Text] [Related]
6. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy. Scott-Douglas N; Zimmerman D; Klassen J Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226 [No Abstract] [Full Text] [Related]
7. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years. Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765 [TBL] [Abstract][Full Text] [Related]
8. Accelerated acute rejection in renal allograft. Han DJ; Yoon HS; Lee HM Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738 [No Abstract] [Full Text] [Related]
9. Safety and efficacy of long-term cyclosporine-ketoconazole administration and preliminary results of a randomized trial. First MR; Schroeder TJ; Michael A; Hariharan S; Weiskittel P; Alexander JW Transplant Proc; 1993 Feb; 25(1 Pt 1):591-4. PubMed ID: 8438428 [No Abstract] [Full Text] [Related]
10. Optimal combination of immunosuppressive agents for renal transplantation: first report of a multicentre, randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and with triple therapy in cadaver renal transplantation. The Australian Collaborative Trials Committee. Hardie IR; Tiller DJ; Mahony JF; Miach PJ; Thomson NM; Thatcher GN; Rigby RJ; Menzies BL Transplant Proc; 1993 Feb; 25(1 Pt 1):583-4. PubMed ID: 8438424 [No Abstract] [Full Text] [Related]
11. Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. Howard RJ; Pfaff WW; Brunson ME; Ramos EL; Peterson JC; Croker BP; Scornik JC; Parris CJ; Fennell RS Transplant Proc; 1993 Feb; 25(1 Pt 2):884. PubMed ID: 8442256 [No Abstract] [Full Text] [Related]
12. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival. Bauma WD; Tang IY; Maddux MS; Veremis SA; Pollak R; Mozes MF Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422 [No Abstract] [Full Text] [Related]
13. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors. Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911 [No Abstract] [Full Text] [Related]
14. Superior long-term kidney graft survival in patients on maintenance immunosuppression with cyclosporine and azathioprine. Opelz G Transplant Proc; 1993 Feb; 25(1 Pt 2):1289-90. PubMed ID: 8442115 [No Abstract] [Full Text] [Related]
15. Rapamycin in a porcine renal transplant model. Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452 [No Abstract] [Full Text] [Related]
16. The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation. Landsberg D; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD Transplant Proc; 1989 Apr; 21(2):3323-4. PubMed ID: 2652826 [No Abstract] [Full Text] [Related]
17. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation? Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519 [No Abstract] [Full Text] [Related]
18. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine. Chapman JR; Morris PJ Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664 [No Abstract] [Full Text] [Related]